Most patients notice: Reduced hunger throughout the day Feeling full faster when eating Less frequent cravings More consistent calorie control Because of this, it becomes much easier to maintain a calorie deficit without relying only on willpower
Emerging pharmacotherapies for diabetic macular edema
The medication mimics GLP-1 to suppress appetite and help the pancreas make more insulin
Lipid Panel Semaglutide therapy has been shown to improve lipid profiles, including reducing LDL cholesterol and triglycerides while increasing HDL cholesterol
Together, these therapies provide a science-based approach to total wellness, helping you feel stronger, more energized, and fully supported in your long-term health journey
According to Grigson, Because our preliminary data suggested that patients did better in the study if they were on both the GLP-1 drug and medication for opioid use disorder, in this study, half of the participants will be on methadone and half will be on buprenorphine for opioid use disorder treatment. Because semaglutide is stronger, is dosed weekly instead of daily, and has fewer gastrointestinal side effects than liraglutide, it may be even more effective in reducing craving while increasing real-world treatment adherence
